Saroja Pharma In

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0PCL01011
  • NSEID: SAROJA
  • BSEID:
INR
36.00
0.00 (0.00%)
BSENSE

Jan 19

BSE+NSE Vol: 4800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024

Compare Balance Sheet Results of Saroja Pharma In
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.02
5.46
-1.44
-26.37%
Share Warrants & Outstandings
Total Reserve
11.66
29.29
-17.63
-60.19%
Shareholder's Funds
15.68
34.75
-19.07
-54.88%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.38
1.92
-0.54
-28.13%
Secured Loans
0.40
1.92
-1.52
-79.17%
Unsecured Loans
0.98
0.00
0.98
0.00%
Deferred Tax Assets / Liabilities
0.01
0.21
-0.20
-95.24%
Other Long Term Liabilities
0.00
0.19
-0.19
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.65
-0.65
-100.00%
Total Non-Current Liabilities
1.39
2.97
-1.58
-53.20%
Current Liabilities
Trade Payables
13.65
0.05
13.60
27,200.00%
Other Current Liabilities
0.77
1.75
-0.98
-56.00%
Short Term Borrowings
8.08
0.00
8.08
0.00%
Short Term Provisions
0.00
0.35
-0.35
-100.00%
Total Current Liabilities
22.49
2.15
20.34
946.05%
Total Liabilities
39.55
39.87
-0.32
-0.80%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.85
6.53
-3.68
-56.36%
Less: Accumulated Depreciation
0.34
3.46
-3.12
-90.17%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.51
3.07
-0.56
-18.24%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
8.61
0.00
8.61
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.34
29.32
-28.98
-98.84%
Long Term Loans & Advances
0.88
0.36
0.52
144.44%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
12.34
33.06
-20.72
-62.67%
Current Assets Loans & Advances
Current Investments
0.00
5.83
-5.83
-100.00%
Inventories
0.10
0.00
0.10
0.00%
Sundry Debtors
26.58
0.33
26.25
7,954.55%
Cash and Bank
0.33
0.42
-0.09
-21.43%
Other Current Assets
0.16
0.06
0.10
166.67%
Short Term Loans and Advances
0.05
0.17
-0.12
-70.59%
Total Current Assets
27.22
6.82
20.40
299.12%
Net Current Assets (Including Current Investments)
4.73
4.66
0.07
1.50%
Total Current Assets Excluding Current Investments
27.22
0.98
26.24
2,677.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
39.55
39.87
-0.32
-0.80%
Contingent Liabilities
0.00
4.68
-4.68
-100.00%
Total Debt
9.46
1.92
7.54
392.71%
Book Value per share (adjusted)
38.99
63.63
-24.64
-38.72%
Annual - Borrowings
Borrowings 9.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 11.12 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024

Annual - Investments
Investments 0.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024

Annual - Current Assets
Current Assets 27.22 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024